AVERTing contrast nephropathy--delivering less to get more?
Delivered contrast volume is the major modifiable risk factor for contrast nephropathy. The AVERT system can divert 31-40% of contrast for peripheral angiography. The upcoming results of the AVERT clinical trial will demonstrate whether the AVERT system reduces contrast nephropathy.